# The Effect of N115 on Coughing in IPF Patients

> **NCT06037408** · PHASE3 · COMPLETED · sponsor: **Cellular Sciences, inc.** · enrollment: 50 (actual)

## Conditions studied

- Idiopathic Pulmonary Fibrosis

## Interventions

- **DRUG:** 20mM sodium pyruvate nasal spray
- **OTHER:** Saline Placebo control nasal spray

## Key facts

- **NCT ID:** NCT06037408
- **Lead sponsor:** Cellular Sciences, inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-15
- **Primary completion:** 2024-05-16
- **Final completion:** 2024-05-20
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-08-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06037408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06037408, "The Effect of N115 on Coughing in IPF Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06037408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*